A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19

Author:

Allerton Charlotte M. N.1,Arcari Joel T.2,Aschenbrenner Lisa M.2,Avery Melissa2,Bechle Bruce M.2,Behzadi Mohammad Amin3,Boras Britton4ORCID,Buzon Leanne M.2,Cardin Rhonda D.3,Catlin Natasha R.2,Carlo Anthony A.2,Coffman Karen J.2,Dantonio Alyssa2,Di Li2ORCID,Eng Heather2,Farley Kathleen A.2ORCID,Ferre Rose Ann4,Gernhardt Steven S.2,Gibson Scott A.5,Greasley Samantha E.4,Greenfield Siennah R.1,Hurst Brett L.5,Kalgutkar Amit S.1ORCID,Kimoto Emi2ORCID,Lanyon Lorraine F.2,Lovett Gabrielle H.1,Lian Yajing2,Liu Wei4,Martínez Alsina Luis A.2,Noell Stephen2,Obach R. Scott2,Owen Dafydd R.1ORCID,Patel Nandini C.1ORCID,Rai Devendra K.2,Reese Matthew R.2,Rothan Hussin A.3,Sakata Sylvie4,Sammons Matthew F.1ORCID,Sathish Jean G.3,Sharma Raman2,Steppan Claire M.2,Tuttle Jamison B.1,Verhoest Patrick R.1,Wei Liuqing2,Yang Qingyi1ORCID,Yurgelonis Irina3,Zhu Yuao3

Affiliation:

1. Pfizer Research & Development, Cambridge, Massachusetts 02139, United States

2. Pfizer Research & Development, Groton, Connecticut 06340, United States

3. Pfizer Research & Development, Pearl River, New York 10965, United States

4. Pfizer Research & Development, La Jolla, California 92121, United States

5. Institute for Antiviral Research, Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, Utah 84322, United States

Publisher

American Chemical Society (ACS)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3